- Home
- MCB vs MRVI Comparison
MCB vs MRVI Comparison
Compare MCB & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCB | MRVI |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MCB | MRVI |
|---|---|---|
| Price | $87.50 | $7.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $105.33 | $7.83 |
| AVG Volume (30 Days) | 99.7K | ★ 2.2M |
| Earning Date | 10-20-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.58% | N/A |
| EPS Growth | 11.64 | ★ 14.29 |
| EPS | ★ 4.40 | N/A |
| Revenue | $11,053,000.00 | ★ $185,743,000.00 |
| Revenue This Year | $20.34 | $14.01 |
| Revenue Next Year | $13.88 | $6.20 |
| P/E Ratio | $20.15 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $64.66 | $2.55 |
| 52 Week High | $102.04 | $9.42 |
Technical Indicators
Market Signals| Indicator | MCB | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 38.04 | 49.87 |
| Support Level | $86.55 | $5.54 |
| Resistance Level | $93.55 | $7.60 |
| Average True Range (ATR) | 1.86 | 0.45 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 32.17 | 30.29 |
Price Performance
Historical ComparisonAbout MCB Metropolitan Bank Holding Corp.
Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.